The “4S Pathway” offers strategies for realigning treatment goals and approaches for older adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) who are struggling with self-management.

Drug sensitivity analysis highlights the effects of imatinib and metformin, revealing metformin's unique role in modulating immune pathways, which supports its potential as a therapeutic agent for ...

Today, the American Diabetes Association® (ADA) announced the awardees of the 2025 Pathway to Stop Diabetes® (Pathway) grants. This year's grants dedicate more than $6.1 million to support ...